Operating income increased 69.4%
Operating income changed +69.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +69.4% from the comparable as-filed period.
Operating margin changed +24539 basis points from the comparable as-filed period.
Capex / revenue changed +567 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed -86.9% from the comparable as-filed period.
Selling, general & administrative changed -54.2% from the comparable as-filed period.
Shares outstanding changed -94.4% from the comparable as-filed period. The change ranks at the 40th percentile of 5 prior comparable changes.
Working capital / assets changed +392 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.